Cargando…
Management of Chronic Symptoms of Lyme Disease With Intravenous Ceftriaxone
Lyme disease is a vector-borne illness of North America and Europe transmitted by Borrelia burgdorferi, over 30,000 cases are reported in the United States yearly. Patients typically present having early localized disease with fevers, headaches, myalgias, and a single erythema migrans. Usually, oral...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359626/ https://www.ncbi.nlm.nih.gov/pubmed/34395132 http://dx.doi.org/10.7759/cureus.16354 |
_version_ | 1783737586680856576 |
---|---|
author | Naeem, Muhammad Enos, Derek Shah, Shazia Patel, Nidhi Fisher, Tara |
author_facet | Naeem, Muhammad Enos, Derek Shah, Shazia Patel, Nidhi Fisher, Tara |
author_sort | Naeem, Muhammad |
collection | PubMed |
description | Lyme disease is a vector-borne illness of North America and Europe transmitted by Borrelia burgdorferi, over 30,000 cases are reported in the United States yearly. Patients typically present having early localized disease with fevers, headaches, myalgias, and a single erythema migrans. Usually, oral doxycycline is administered with a good disease prognosis but we report the case of a 58-year-old male who presented with Lyme disease diagnosed by immunoassay; he was treated with doxycycline but was refractory and saw an improvement in his symptoms with IV ceftriaxone. |
format | Online Article Text |
id | pubmed-8359626 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-83596262021-08-13 Management of Chronic Symptoms of Lyme Disease With Intravenous Ceftriaxone Naeem, Muhammad Enos, Derek Shah, Shazia Patel, Nidhi Fisher, Tara Cureus Internal Medicine Lyme disease is a vector-borne illness of North America and Europe transmitted by Borrelia burgdorferi, over 30,000 cases are reported in the United States yearly. Patients typically present having early localized disease with fevers, headaches, myalgias, and a single erythema migrans. Usually, oral doxycycline is administered with a good disease prognosis but we report the case of a 58-year-old male who presented with Lyme disease diagnosed by immunoassay; he was treated with doxycycline but was refractory and saw an improvement in his symptoms with IV ceftriaxone. Cureus 2021-07-13 /pmc/articles/PMC8359626/ /pubmed/34395132 http://dx.doi.org/10.7759/cureus.16354 Text en Copyright © 2021, Naeem et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine Naeem, Muhammad Enos, Derek Shah, Shazia Patel, Nidhi Fisher, Tara Management of Chronic Symptoms of Lyme Disease With Intravenous Ceftriaxone |
title | Management of Chronic Symptoms of Lyme Disease With Intravenous Ceftriaxone |
title_full | Management of Chronic Symptoms of Lyme Disease With Intravenous Ceftriaxone |
title_fullStr | Management of Chronic Symptoms of Lyme Disease With Intravenous Ceftriaxone |
title_full_unstemmed | Management of Chronic Symptoms of Lyme Disease With Intravenous Ceftriaxone |
title_short | Management of Chronic Symptoms of Lyme Disease With Intravenous Ceftriaxone |
title_sort | management of chronic symptoms of lyme disease with intravenous ceftriaxone |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359626/ https://www.ncbi.nlm.nih.gov/pubmed/34395132 http://dx.doi.org/10.7759/cureus.16354 |
work_keys_str_mv | AT naeemmuhammad managementofchronicsymptomsoflymediseasewithintravenousceftriaxone AT enosderek managementofchronicsymptomsoflymediseasewithintravenousceftriaxone AT shahshazia managementofchronicsymptomsoflymediseasewithintravenousceftriaxone AT patelnidhi managementofchronicsymptomsoflymediseasewithintravenousceftriaxone AT fishertara managementofchronicsymptomsoflymediseasewithintravenousceftriaxone |